2076975 2077203
최종편집 2024-03-29 06:02 (금)
Demand for the domestic pharmaceutical product seems to have a hope of a rebound
상태바
Demand for the domestic pharmaceutical product seems to have a hope of a rebound
  • Hyeokgi Lee, Newsmp
  • 승인 2021.05.03 16:54
  • 댓글 0
이 기사를 공유합니다

Retail sales in March close to 1.9 trillion won… a negative growth reduced
Outpatient prescription back to 1.2 trillion won… returned to positive growth
Exports continue to grow… $2.4 billion in 1Q, YoY 70.7%↑

As the aftermath of the third wave of the COVID-19 pandemic continues since the end of 2020, the demand for domestic pharmaceutical products remains depressed.

Nevertheless, there are hints of reversal, such as an increase in growth or a small rebound in March.

Data from Statistics Korea shows retail sales of pharmaceutical products fell 4.6% YoY to 1.89 trillion won in March, continuing a negative growth trend for three consecutive months.

▲ As the aftermath of the third wave of the COVID-19 pandemic continues since the end of 2020, the demand for domestic pharmaceutical products remains depressed.
▲ As the aftermath of the third wave of the COVID-19 pandemic continues since the end of 2020, the demand for domestic pharmaceutical products remains depressed.

Pharmaceutical retail sales, which had grown rapidly until the third quarter of last year, slowed significantly in the fourth quarter.

Finally, this year, it is below the 1.9 trillion mark for three months, recording negative growth for three straight months.

Its accumulated retail sales in 1Q also dropped 4.6% YoY to 5.4777 trillion won.

However, the growth in retail sales, which fell to -9.0% in February, rose to -2.0% in March, and its size is close to 1.9 trillion won, showing signs of recovery gradually.

The outpatient prescription appears to be recovering a little faster. Even during the peak season in January, the amount of outpatient prescription, which fell 7.0% YoY, remained at 1.1 trillion won in February, and the drop was reduced to 5.6%.

It then grew 1.9% YoY to 1.25 trillion won in March, returning to a 1.2 trillion won mark in three months since December last year, and also escaped from the downtrend that lasted for three months.

The cumulative outpatient prescription in 1Q decreased by 3.6% YoY to 3.569 trillion won in the aftermath of sluggishness in January and February. 

Meanwhile, exports (SITC 54) continued to boom while domestic indicators are rebounding.

Exports nearly reached $900 million by $880.91 million in March, surpassing $800 million for the first time this year.

However, pharmaceutical exports began to increase dramatically in March last year due to the COVID-19 pandemic, and the growth from the same period last year fell to 50.4%, down from January and February due to the base effect.

Nevertheless, it still maintains a growth of over 50%, with quarterly exports reaching $2.4 billion, up 70.7% YoY.
 


댓글삭제
삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
댓글쓰기
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.